Hepatic portal cholangiocarcinoma: a clinical analysis of 70 cases.
BACKGROUND
The incidence of hepatic portal cholangiocarcinoma is increasing and it is always associated with poor survival. This study analyzed an effective therapeutic method.


METHODS
A retrospective analysis was made on 70 patients with hepatic portal cholangiocarcinoma admitted between January 2004 and February 2007 to the General Hospital of Air Force PLA.


RESULTS
Forty-seven patients had hepatic duct-jejunum anastomosis after resection of hepatic portal cholangiocarcinoma. Internal or external biliary drainage and canals for internal radiation were performed in those patients unfit for operation. Among the 70 patients, 5 died within 15 months, 27 survived more than 24 months, and the others survived 4-18 months.


CONCLUSIONS
Surgery is the primary therapeutic method for hepatic portal cholangiocarcinoma. Internal or external biliary drainage can prolong the life-span.
Zhang
Hong-Yi
HY
Department of Hepatobiliary Surgery, General Hospital of Air Force PLA, Beijing 100036, China. zhhyiyi1487@163.com
Kong
Ya-Lin
YL
Zhang
Hong-Yi
HY
He
Xiao-Jun
XJ
Zhang
Hui
H
Liu
Cheng-Li
CL
Zhao
Gang
G
Xiao
Mei
M
Zhang
Xi-Dong
XD
Feng
Zhi-Qiang
ZQ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000713:Anastomosis, Roux-en-Y / Q000009:adverse effects; D001650:Bile Duct Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D001653:Bile Ducts, Intrahepatic / Q000528:radiation effects / Q000601:surgery*; D001662:Biliary Tract Surgical Procedures / Q000009:adverse effects; D018281:Cholangiocarcinoma / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D004322:Drainage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult